Reply to Tomasz Drewa and Piotr Chlosta's Letter to the Editor re: Frans Debruyne, Arkadij A. Gres, Dmitrii L. Arustamov. Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia. Eur Urol 2008;54:170–80

✍ Scribed by Frans Debruyne; Arkadij A. Gres; Dmitrii L. Arustamov

• Book ID: 113611028
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 70 KB
• Volume: 55
• Category: Article
• ISSN: 0302-2838
• DOI: 10.1016/j.eururo.2008.08.006